Bayer

Aflibercept 8 mg met primary endpoint in phase III study and demonstrates vision gains with extended treatment intervals in retinal vein occlusion

17 Dec 2024

Acoramidis receives positive CHMP opinion for treatment of transthyretin amyloid cardiomyopathy

13 Dec 2024

Bayer starts Phase I study with SOS1 inhibitor in patients with advanced KRAS-mutated tumors

12 Dec 2024

Bayer acquires HiDoc Technologies and Cara Care® app for irritable bowel syndrome

11 Dec 2024

Articles tagged with 'further health topics' | Bayer

11 Dec 2024

Bayer to present new analyses from FINEARTS-HF with finerenone

11 Dec 2024

SILAL and Bayer Advance Agricultural Innovation Partnership with Comprehensive Memorandum of Understanding

11 Dec 2024

Bayer replaces credit line and increases volume to 5 billion euros

06 Dec 2024

Bayer showcases innovations in radiology portfolio at RSNA 2024

02 Dec 2024

Bayer further expands global incubator network with Bayer Co.Lab Berlin and welcomes MyoPax as first resident

28 Nov 2024